Myeloma Archives - Page 2 of 19 - Curetalks

CRISPR-edited Immune Cells Enhance Fight Against Blood Cancers

The Nobel prize winning CRISPR-Cas9 genome editing system is being explored for its potential use in cancer research and treatment. By deleting, inactivating, or otherwise modifying specific genes in cultured cells or in animal models, researchers have been able to…

Jun 29, 2021, 10:00 am 0 Listen

UltraCAR-T Therapy – Scope & Possibilities in Multiple Myeloma Management

Ongoing clinical trials are investigating the safety and efficacy of a new type of CAR T (Chimeric antigen receptor T-cells) therapy called UltraCAR-T therapy for myeloid malignancies. Unlike current CAR T cells, which utilize viruses to attach the CAR to…

May 17, 2021, 10:00 am 4 Listen

Melflufen for Myeloma: A Deep Dive

The FDA recently granted priority review to a new drug application for melflufen (INN melphalan flufenamide), in combination with dexamethasone. Melflufen is intended for use as a first choice for patients with multiple myeloma whose disease is refractory to at…

Feb 18, 2021, 11:00 am 9 Listen

ASH 2020 Updates: CAR T Cell Therapies in Multiple Myeloma

We kickstart the new year with a discussion on CAR T cells in myeloma treatment with a focus on the CT053, a CAR T-cell therapy targeting the BCMA protein and granted orphan drug status by the U.S. Food and Drug…

Jan 27, 2021, 10:00 am 4 Listen

Novel Cancer Immunotherapies with SELLAS Life Sciences

The second episode of CureTalks with Gary discusses new immunotherapies with Sellas Life Sciences. Talking to Gary Petersen is Dr Angelos M. Stergiou CEO and President of Sellas Life Sciences and Senior Advisor for Sellas, Dr. Nicholas J Sarlis.  Sellas…

Nov 24, 2020, 03:13 am 0 Listen